In a Parkinson’s disease mouse model, DP189 downregulates NLRP3 and NF-κB signaling, thereby reducing neuroinflammation and influencing the gut–brain axis (L. Wang et al., 2022). Here, NLRP3 is linked to Parkinson disease.